» Authors » Mark Wakulchik

Mark Wakulchik

Explore the profile of Mark Wakulchik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 52
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Witkin J, Shenvi R, Li X, Gleason S, Weiss J, Morrow D, et al.
Biochem Pharmacol . 2018 Jun; 155:61-70. PMID: 29940173
The 'neurotrophic sesquiterpenes' refer to a group of molecules derived from the Illicium genus of flowering plant. They display neurotrophic effects in cultured neuron preparations and have been suggested to...
2.
Xu N, Ernst M, Treven M, Cerne R, Wakulchik M, Li X, et al.
Psychopharmacology (Berl) . 2018 Jan; 235(4):1151-1161. PMID: 29374303
Rationale: Associated with frank neuropathology, patients with Alzheimer's disease suffer from a host of neuropsychiatric symptoms that include depression, apathy, agitation, and aggression. Negative allosteric modulators (NAMs) of α5-containing GABA...
3.
Cerne R, Wakulchik M, Krambis M, Burris K, Priest B
Assay Drug Dev Technol . 2016 Feb; 14(2):84-92. PMID: 26844665
Voltage-gated sodium channels represent important drug targets. The implementation of higher throughput electrophysiology assays is necessary to characterize the interaction of test compounds with several conformational states of the channel,...
4.
Jambrina E, Cerne R, Smith E, Scampavia L, Cuadrado M, Findlay J, et al.
J Biomol Screen . 2016 Feb; 21(5):468-79. PMID: 26838761
N-methyl-D-aspartate receptors (NMDARs) are ionotropic glutamate receptors that play an important role in synaptic plasticity and learning and memory formation. Malfunctioning of NMDARs, in particular the reduction in NMDAR activity,...
5.
Cerne R, Wakulchik M, Li B, Burris K, Priest B
Assay Drug Dev Technol . 2015 Dec; 14(2):75-83. PMID: 26716356
Voltage-gated calcium channels represent important drug targets. The implementation of higher throughput electrophysiology assays is necessary to characterize the interaction of test compounds with several conformational states of the channel,...
6.
Yip Y, Victor F, LaMar J, Johnson R, Wang Q, Glass J, et al.
Bioorg Med Chem Lett . 2004 Sep; 14(19):5007-11. PMID: 15341970
With the aim of improving HCV protease inhibitors reported in our previous manuscripts, we synthesized and evaluated a series of 1a-based tetrapeptidyl alpha-ketoamides with additional P4 modification. The promising analog...
7.
Yip Y, Victor F, LaMar J, Johnson R, Wang Q, Barket D, et al.
Bioorg Med Chem Lett . 2003 Dec; 14(1):251-6. PMID: 14684337
We describe herein the design, syntheses and evaluation of a number of bicycloproline P2 bearing HCV protease inhibitors endowed with impressive enzyme potency, enzyme selectivity, cellular activity and favorable ADME...
8.
Chen S, LaMar J, Victor F, Snyder N, Johnson R, Heinz B, et al.
Bioorg Med Chem Lett . 2003 Sep; 13(20):3531-6. PMID: 14505664
We describe herein the synthesis and biological evaluation of a series of tripeptidyl alpha-ketoamides as human rhinovirus (HRV) 3C protease inhibitors. The most potent inhibitor discussed in this manuscript, 4I,...